If youre putting in the workeating well, staying activebut still feel like youve hit a wall, youre not alone
The Latest Research: TRIUMPH-1 Phase 3 Results (May 2026) In May 2026, Eli Lilly announced topline results from TRIUMPH-1, a Phase 3 clinical trial involving 2,339 adults with obesity or overweight who did not have type 2 diabetes
All 11 studies were randomised placebo-controlled trials investigating GLP-1 receptor agonists in adults with high cardiovascular risk
To hit the middle calf muscle of each rat, a stainless-steel hammer weighing 300 g was dropped from a height of 50 cm five consecutive times
Light exposure accelerates degradation, so amber vials or aluminum foil wrapping helps preserve potency
The dual GIP/GLP-1 receptor stimulation stops, and hunger signaling reverts to its pre-treatment pattern